Biomarkers can indicate alterations in signaling pathways, for example, changes that are critical for cancerous cell growth, as in the case of EGFR or PI3K activity, representing a druggable target activity necessary for tumor growth and survival [146,147]. The gene discussed is EGFR; the disease is neoplasm.